Medprin Regenerative Medical Technologies Co (SZSE:301033) Tariff Resilience Score: 0/10 (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:301033 Medprin Regenerative Medical Technologies Co Ltd SZSE:301033
78 GF Score
Price ¥55.05
GF Value ¥75.61
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Medprin Regenerative Medical Technologies Co Tariff Resilience Score?

Medprin Regenerative Medical Technologies Co has the Tariff Resilience Score of 0, which implies that the company might have .

Medprin Regenerative Medical Technologies Co has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Medprin Regenerative Medical Technologies Co might have .


Medprin Regenerative Medical Technologies Co  (SZSE:301033) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Medprin Regenerative Medical Technologies Co Tariff Resilience Score Related Terms

SZSE:301033
78GF Score
Medprin Regenerative Medical Technologies Co Ltd SZSE:301033
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medprin Regenerative Medical Technologies Co (SZSE:301033) Overvalued in 2026?

Based on GuruFocus' analysis, Medprin Regenerative Medical Technologies Co stock appears to be undervalued. The current stock price of ¥55.05 is trading 27.2% below its estimated GF Value™ of ¥75.61. GuruFocus considers Medprin Regenerative Medical Technologies Co to be Modestly Undervalued.

Key valuation signals for SZSE:301033:

  • Tariff Resilience Score: 0
  • GF Value™: ¥75.61 vs. price of ¥55.05 (27.2% below fair value)
  • GF Score™: 78/100 with 1 warning sign

No single metric tells the full story. See the SZSE:301033 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medprin Regenerative Medical Technologies Co Business Description

Address No. 80 Lanyue Road, 3rd Floor, Area E, High-tech Industrial Development Zone, Guangdong Province, Science City, Guangzhou, CHN, 510700
Medprin Regenerative Medical Technologies Co Ltd is engaged in the development and manufacturing of high-performance implanted medical devices.
78GF Score

Get the complete analysis for SZSE:301033

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥55.05
Price
¥75.61
GF Value